The company was founded in 1998. The company is a leading enterprise in the orthopedic industry in China. It has filled the gaps in the domestic market with a variety of innovative products, established a unique market advantage and leading position in the industry, and significantly enhanced the company's core competitiveness and industry recognition. We are committed to solving key technical problems in the industry and promoting the continuous improvement of the level of independent innovation in the domestic joint field. The company's main business is R&D, production and sales of implantable orthopedic medical devices. The company's main products are orthopedic medical devices and tissue repair series products, including spinal, trauma, joint, sports medicine, bone repair material implants, surgical instrument products, platelet-rich plasma (PRP) preparation kits, and negative pressure drainage kits for closed trauma. Honors: National Intellectual Property Advantage Enterprise selected by the State Intellectual Property Office in 2023; recognized as a national enterprise technology center by the Development and Reform Commission of the People's Republic of China; the company's “Mass Customization of Typical Application Scenarios” project was approved at the national level “2021 Intelligent Manufacturing Excellent Scenario List”; issued by the Ministry of Industry and Information Technology in 2022; 25th in the Beijing Top 100 Specialized and New Enterprises list in 2023. Ranked 66th on the strong list, won the “Artificial Intelligence Medical Device Innovation Task Award Winner” unit in 2024, and won honors such as “Single Champion Enterprise in the Manufacturing Industry” in 2024.